Cargando…
Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk
We compared accuracy for breast cancer (BC) risk stratification of a new fully automated system (DenSeeMammo—DSM) for breast density (BD) assessment to a non-inferiority threshold based on radiologists’ visual assessment. Pooled analysis was performed on 14,267 2D mammograms collected from women age...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494838/ https://www.ncbi.nlm.nih.gov/pubmed/34615978 http://dx.doi.org/10.1038/s41598-021-99433-3 |
_version_ | 1784579402848272384 |
---|---|
author | Giorgi Rossi, Paolo Djuric, Olivera Hélin, Valerie Astley, Susan Mantellini, Paola Nitrosi, Andrea Harkness, Elaine F. Gauthier, Emilien Puliti, Donella Balleyguier, Corinne Baron, Camille Gilbert, Fiona J. Grivegnée, André Pattacini, Pierpaolo Michiels, Stefan Delaloge, Suzette |
author_facet | Giorgi Rossi, Paolo Djuric, Olivera Hélin, Valerie Astley, Susan Mantellini, Paola Nitrosi, Andrea Harkness, Elaine F. Gauthier, Emilien Puliti, Donella Balleyguier, Corinne Baron, Camille Gilbert, Fiona J. Grivegnée, André Pattacini, Pierpaolo Michiels, Stefan Delaloge, Suzette |
author_sort | Giorgi Rossi, Paolo |
collection | PubMed |
description | We compared accuracy for breast cancer (BC) risk stratification of a new fully automated system (DenSeeMammo—DSM) for breast density (BD) assessment to a non-inferiority threshold based on radiologists’ visual assessment. Pooled analysis was performed on 14,267 2D mammograms collected from women aged 48–55 years who underwent BC screening within three studies: RETomo, Florence study and PROCAS. BD was expressed through clinical Breast Imaging Reporting and Data System (BI-RADS) density classification. Women in BI-RADS D category had a 2.6 (95% CI 1.5–4.4) and a 3.6 (95% CI 1.4–9.3) times higher risk of incident and interval cancer, respectively, than women in the two lowest BD categories. The ability of DSM to predict risk of incident cancer was non-inferior to radiologists’ visual assessment as both point estimate and lower bound of 95% CI (AUC 0.589; 95% CI 0.580–0.597) were above the predefined visual assessment threshold (AUC 0.571). AUC for interval (AUC 0.631; 95% CI 0.623–0.639) cancers was even higher. BD assessed with new fully automated method is positively associated with BC risk and is not inferior to radiologists’ visual assessment. It is an even stronger marker of interval cancer, confirming an appreciable masking effect of BD that reduces mammography sensitivity. |
format | Online Article Text |
id | pubmed-8494838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84948382021-10-08 Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk Giorgi Rossi, Paolo Djuric, Olivera Hélin, Valerie Astley, Susan Mantellini, Paola Nitrosi, Andrea Harkness, Elaine F. Gauthier, Emilien Puliti, Donella Balleyguier, Corinne Baron, Camille Gilbert, Fiona J. Grivegnée, André Pattacini, Pierpaolo Michiels, Stefan Delaloge, Suzette Sci Rep Article We compared accuracy for breast cancer (BC) risk stratification of a new fully automated system (DenSeeMammo—DSM) for breast density (BD) assessment to a non-inferiority threshold based on radiologists’ visual assessment. Pooled analysis was performed on 14,267 2D mammograms collected from women aged 48–55 years who underwent BC screening within three studies: RETomo, Florence study and PROCAS. BD was expressed through clinical Breast Imaging Reporting and Data System (BI-RADS) density classification. Women in BI-RADS D category had a 2.6 (95% CI 1.5–4.4) and a 3.6 (95% CI 1.4–9.3) times higher risk of incident and interval cancer, respectively, than women in the two lowest BD categories. The ability of DSM to predict risk of incident cancer was non-inferior to radiologists’ visual assessment as both point estimate and lower bound of 95% CI (AUC 0.589; 95% CI 0.580–0.597) were above the predefined visual assessment threshold (AUC 0.571). AUC for interval (AUC 0.631; 95% CI 0.623–0.639) cancers was even higher. BD assessed with new fully automated method is positively associated with BC risk and is not inferior to radiologists’ visual assessment. It is an even stronger marker of interval cancer, confirming an appreciable masking effect of BD that reduces mammography sensitivity. Nature Publishing Group UK 2021-10-06 /pmc/articles/PMC8494838/ /pubmed/34615978 http://dx.doi.org/10.1038/s41598-021-99433-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Giorgi Rossi, Paolo Djuric, Olivera Hélin, Valerie Astley, Susan Mantellini, Paola Nitrosi, Andrea Harkness, Elaine F. Gauthier, Emilien Puliti, Donella Balleyguier, Corinne Baron, Camille Gilbert, Fiona J. Grivegnée, André Pattacini, Pierpaolo Michiels, Stefan Delaloge, Suzette Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk |
title | Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk |
title_full | Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk |
title_fullStr | Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk |
title_full_unstemmed | Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk |
title_short | Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk |
title_sort | validation of a new fully automated software for 2d digital mammographic breast density evaluation in predicting breast cancer risk |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494838/ https://www.ncbi.nlm.nih.gov/pubmed/34615978 http://dx.doi.org/10.1038/s41598-021-99433-3 |
work_keys_str_mv | AT giorgirossipaolo validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT djuricolivera validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT helinvalerie validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT astleysusan validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT mantellinipaola validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT nitrosiandrea validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT harknesselainef validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT gauthieremilien validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT pulitidonella validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT balleyguiercorinne validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT baroncamille validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT gilbertfionaj validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT grivegneeandre validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT pattacinipierpaolo validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT michielsstefan validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk AT delalogesuzette validationofanewfullyautomatedsoftwarefor2ddigitalmammographicbreastdensityevaluationinpredictingbreastcancerrisk |